Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-026977·Lincoln Alternative Strategies LLC
Schedule 13G ownership disclosure
PURPLE BIOTECH LTD
American Depositary Shares, each representing 200 Ordinary Shares · CUSIP: 74638P208
Event date: 2025-09-04
- Filing-level shares
- 605,000.00
- Percent of class
- 9.9%
- Lincoln Alternative Strategies LLC
Shares: 605,000.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-026977
- Form type
- SCHEDULE 13G
- Filer
- Lincoln Alternative Strategies LLC
- CIK
- CIK 2043812
- Filed
- Sep 09, 2025
- Reporting period
- Sep 04, 2025
- Description
- Schedule 13G beneficial ownership